Boston Children's Hospital/Harvard Medical School

Boston, Massachusetts 02115

0 studies enrolling now · 4 studies all time

What they study most

Rett Syndrome, Tuberous Sclerosis Complex

Studies at this site

• Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related Epilepsy — Stopped early
• Open-Label Extension Study of Trofinetide for Rett Syndrome — Stopped early
• An Open-Label Study of Trofinetide for the Treatment of Girls Two to Five Years of Age Who Have Rett Syndrome — Stopped early
• Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LAVENDER™) — Completed